We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+2.98%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$106B
AUM Growth
+$6.52B
Cap. Flow
+$4.41B
Cap. Flow %
4.14%
Top 10 Hldgs %
13.68%
Holding
3,236
New
179
Increased
2,227
Reduced
440
Closed
133

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$115M
2
AAPL icon
Apple
AAPL
+$95.4M
3
DXC icon
DXC Technology
DXC
+$91M
4
PFE icon
Pfizer
PFE
+$66.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$60.4M

Sector Composition

Rank Sector Weight
1 Technology 14.68%
2 Financials 14.59%
3 Healthcare 13.17%
4 Industrials 11.08%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCKT icon
3126
Rocket Pharmaceuticals
RCKT
$344M
-6,950
Closed -$56K
RGLS
3127
DELISTED
Regulus Therapeutics
RGLS
-515
Closed -$102K
SILC icon
3128
Silicom
SILC
$212M
-8,600
Closed -$428K
DCOY
3129
Decoy Therapeutics
DCOY
$2.09M
0
-$87K
SLS icon
3130
SELLAS Life Sciences
SLS
$2.08B
-9
Closed -$9K
SPNS
3131
DELISTED
Sapiens International
SPNS
-33,066
Closed -$426K
TDW icon
3132
Tidewater
TDW
$3.65B
-46,804
Closed -$1.74M
TLPH icon
3133
Talphera
TLPH
$68.5M
-2,865
Closed -$181K
TNDM icon
3134
Tandem Diabetes Care
TNDM
$1.27B
-3,539
Closed -$43K
TOVX icon
3135
Theriva Biologics
TOVX
$9.69M
-13
Closed -$75K
TPST icon
3136
Tempest Therapeutics
TPST
$14.3M
-19
Closed -$107K
TRI icon
3137
Thomson Reuters
TRI
$46.5B
-122,013
Closed -$6.12M
TTNP
3138
DELISTED
Titan Pharmaceuticals
TTNP
-8
Closed -$100K
UONEK icon
3139
Urban One Class D
UONEK
$22.9M
-4,120
Closed -$136K
VANI icon
3140
Vivani Medical
VANI
$111M
-5,865
Closed -$171K
VNCE icon
3141
Vince Holding Corp
VNCE
$80.4M
-7,723
Closed -$120K
WKHS icon
3142
Workhorse Group
WKHS
$34.1M
-6
Closed -$49K
NAGE
3143
Niagen Bioscience
NAGE
$259M
-44,800
Closed -$121K
AY
3144
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
-92,484
Closed -$1.94M
ASXC
3145
DELISTED
Asensus Surgical, Inc.
ASXC
-11,054
Closed -$174K
AVGR
3146
DELISTED
Avinger, Inc. Common Stock
AVGR
0
-$34K
TTOO
3147
DELISTED
T2 Biosystems, Inc
TTOO
-4
Closed -$114K
BPTH
3148
DELISTED
Bio-Path Holdings Inc
BPTH
-33
Closed -$109K
MRTX
3149
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-19,648
Closed -$103K
UFAB
3150
DELISTED
Unique Fabricating, Inc.
UFAB
-10,200
Closed -$123K

Similar funds

Charles Schwab's Q2 2017 Portfolio in Review

As of Q2 2017, Charles Schwab held 3,236 positions worth $106B, up 6.5% from $99.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $4.41B of net new capital in Q2 2017, opening 179 new positions and adding to 2,227 existing holdings. Its largest new stake was DXC Technology: 1,371,360 shares worth $91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was HP, an estimated $50.3M trimmed.

  • Charles Schwab's largest Q2 2017 buy was DXC Technology: 1,371,360 shares worth $91M.
  • Charles Schwab added most to ExxonMobil in Q2 2017, an estimated $115M increase.
  • Charles Schwab's biggest Q2 2017 reduction was HP, cutting an estimated $50.3M.
  • Charles Schwab fully exited Yahoo Inc in Q2 2017, selling an estimated $121M.
  • Charles Schwab's ten largest holdings make up 14% of its $106B portfolio in Q2 2017.
  • Charles Schwab opened 179 new positions and closed 133 in Q2 2017.
  • Charles Schwab's portfolio value rose 6.5% quarter-over-quarter to $106B.

Based on Charles Schwab's 13F filing for Q2 2017, filed 2 Aug 2017.